Document Migration

WHITE PAPERS AND CASE STUDIES

• How Digitized Protocols Are Accelerating Clinical Research

  Digitized protocols, enhanced by artificial intelligence (AI), are transforming clinical trial operations by accelerating document generation, system integration, and trial optimization.

• 4 Key FSP Considerations To Optimize Drug Development

  Review several benefits of using a functional service provider model and what four things to consider before choosing a partner to help meet challenging drug development timelines.

• Biotechnology Manufacturing Program Management

  Find out how a global biotechnology manufacturing company executing several interrelated projects achieved critical project objectives while adhering to schedule and financial commitments.

• How To Unlock The Secret To Repeatable, Scalable Low Turnover

  Here, we explore the evolution of a 10-year partnership and extrapolate the principles that create cohesive teams and minimize turnover.

• Gateways To Asia: Market Access In Japan And South Korea

  Learn how the recent developments in market access and regulatory rules in Japan and South Korea have paved the way for expansion in Asia.

• How Early-Stage Planning Strategies Are Optimizing Drug Development

  Early integration of a target product profile (TPP) into early-stage planning is pivotal for steering drug development toward both regulatory success and commercial impact.

• Preparing For Disease X: Effective Vaccine Development In The Face Of A Future Pandemic

  CDMOs are playing a critical role in the global effort to prepare for future pandemics. Learn how innovative strategies and flexible platforms are helping to ensure a swift and effective response plan.

• Innovative FSP Solutions For Biopharma Growth And Transition

  To optimize clinical development, the pharmaceutical industry is increasingly adopting innovative outsourcing strategies with CROs.

• Non-Viral Genetic Modification Using The 4D-Nucleofector LV Unit In CGT

  This paper underscores the 4D-Nucleofector® LV Unit as a pivotal tool for translating genetic modification technologies into scalable, safe, and effective therapeutic solutions.

• A Review Of The Changing Trends And Use Of eCOA In Clinical Trials

  Delve into how electronic clinical outcome assessments are being transformed through new technologies, the maturation of digital organizations, and increased endorsement from regulatory bodies.

• Managing Cash Flow And Financial Risk For Cell And Gene Therapies

  Pharmaceutical companies that are able to mitigate financial risk for CGT providers and ease cash flow burdens will stand out as preferred partners in an increasingly competitive industry.

• Organizational Assessment For A Large MedTech Company

  Explore an organizational assessment run for a medical technology company specializing in tissue repair and regeneration, and the actionable recommendations provided to facilitate future growth.